Seth Lederman - Net Worth and Insider Trading
Seth Lederman Net Worth
The estimated net worth of Seth Lederman is at least $20 dollars as of 2024-11-08. Seth Lederman is the CEO of Tonix Pharmaceuticals Holding Corp and owns about 139 shares of Tonix Pharmaceuticals Holding Corp (TNXP) stock worth over $20. Details can be seen in Seth Lederman's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Seth Lederman has not made any transactions after 2022-06-29 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Seth Lederman
Seth Lederman Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Seth Lederman owns 1 companies in total, including Tonix Pharmaceuticals Holding Corp (TNXP) .
Click here to see the complete history of Seth Lederman’s form 4 insider trades.
Insider Ownership Summary of Seth Lederman
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TNXP | Tonix Pharmaceuticals Holding Corp | 2022-06-29 | director & 10 percent owner & Chief Executive Officer |
Seth Lederman Latest Holdings Summary
Seth Lederman currently owns a total of 1 stock. Seth Lederman owns 139 shares of Tonix Pharmaceuticals Holding Corp (TNXP) as of June 29, 2022, with a value of $20.
Latest Holdings of Seth Lederman
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TNXP | Tonix Pharmaceuticals Holding Corp | 2022-06-29 | 139 | 0.14 | 20 |
Holding Weightings of Seth Lederman
Seth Lederman Form 4 Trading Tracker
According to the SEC Form 4 filings, Seth Lederman has made a total of 7 transactions in Tonix Pharmaceuticals Holding Corp (TNXP) over the past 5 years, including 7 buys and 0 sells. The most-recent trade in Tonix Pharmaceuticals Holding Corp is the acquisition of 100 shares on June 29, 2022, which cost Seth Lederman around $34,200.
Insider Trading History of Seth Lederman
- 1
Seth Lederman Trading Performance
GuruFocus tracks the stock performance after each of Seth Lederman's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Seth Lederman is -19.93%. GuruFocus also compares Seth Lederman's trading performance to market benchmark return within the same time period. The performance of stocks bought by Seth Lederman within 3 months outperforms 11 times out of 30 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Seth Lederman's insider trading performs compared to the benchmark.
Performance of Seth Lederman
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -6.69 | | | | | |
| Relative Return to S&P 500(%) | -9.31 | | | | | |
Seth Lederman Ownership Network
Ownership Network List of Seth Lederman
Ownership Network Relation of Seth Lederman
Seth Lederman Owned Company Details
What does Tonix Pharmaceuticals Holding Corp do?
Who are the key executives at Tonix Pharmaceuticals Holding Corp?
Seth Lederman is the director & 10 percent owner & Chief Executive Officer of Tonix Pharmaceuticals Holding Corp. Other key executives at Tonix Pharmaceuticals Holding Corp include Chief Medical Officer Gregory M Sullivan , Chief Administrative Officer Jessica Edgar Morris , and Chief Financial Officer Bradley Saenger .
Tonix Pharmaceuticals Holding Corp (TNXP) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Tonix Pharmaceuticals Holding Corp (TNXP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Tonix Pharmaceuticals Holding Corp (TNXP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Tonix Pharmaceuticals Holding Corp (TNXP)'s detailed insider trading history can be found in Insider Trading Tracker table.
Tonix Pharmaceuticals Holding Corp Insider Transactions
Seth Lederman Mailing Address
Above is the net worth, insider trading, and ownership report for Seth Lederman. You might contact Seth Lederman via mailing address: C/o Tonix Pharmaceuticals Holding Corp, 509 Madison Ave., Suite 306, New York Ny 10022.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
